Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Berger

Showing results (601-610 of 964) with videos related to

Pageof 97
Sort By:
Archives Internationales De Pharmacodynamie Et De Therapie|November 1, 1985
Pharmacological effects of SCH 30497--a novel analgesic substanceR E Chipkin, M B Latranyi, L C Iorio, et al.
Advanced Healthcare Materials|March 19, 2021
Oxidation-Responsive, Tunable Growth Factor Delivery from Polyelectrolyte-Coated ImplantsJohn R Martin, MayLin T Howard, Sheryl Wang, et al.
European Journal of Biochemistry|February 15, 1993
Purification and characterization of recombinant human beta 1-4 galactosyltransferase expressed in Saccharomyces cerevisiaeC H Krezdorn, G Watzele, R B Kleene, et al.
Zeitschrift Fur Experimentelle Chirurgie, Transplantation, Und Kunstliche Organe : Organ Der Sektion Experimentelle Chirurgie Der Gesellschaft Fur Chirurgie Der DDR|January 1, 1988
[Peri-implantation enzymes and mineralization in bone tissue after implantation of bioactive vitroceramic material--a method for biomaterial testing for hard tissue substitutes. 2. Results of studies of vitroceramics and their modification by the admixture of metal oxides]H Reichelt, S Köhler, G Berger, et al.
Journal of Biomedical Materials Research. Part A|July 20, 2007
Effect of rapidly resorbable bone substitute materials on the temporal expression of the osteoblastic phenotype in vitroC Knabe, A Houshmand, G Berger, et al.
Genomics|November 1, 2002
The murine alpha(1)-proteinase inhibitor gene family: polymorphism, chromosomal location, and structureKaren W Barbour, FuSheng Wei, Camilynn Brannan, et al.
Molecular Pharmacology|October 26, 1999
Mechanisms of acquired resistance to thymidylate synthase inhibitors: the role of enzyme stabilityM E Kitchens, A M Forsthoefel, K W Barbour, et al.
Cancer Research|July 30, 2010
Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathwayXinna Zhang, Guohui Wan, Sizolwenkosi Mlotshwa, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1988
Pharmacology of SCH 34826, an orally active enkephalinase inhibitor analgesicR E Chipkin, J G Berger, W Billard, et al.
Journal of the American Academy of Dermatology|July 30, 1999
Sarcoidosis in a patient with AIDS: a manifestation of immune restoration syndromeP Mirmirani, T A Maurer, B Herndier, et al.
Pageof 97

Showing results (601-610 of 964) with videos related to

Sort By:
Pageof 97
Archives Internationales De Pharmacodynamie Et De Therapie|November 1, 1985
Pharmacological effects of SCH 30497--a novel analgesic substanceR E Chipkin, M B Latranyi, L C Iorio, et al.
Advanced Healthcare Materials|March 19, 2021
Oxidation-Responsive, Tunable Growth Factor Delivery from Polyelectrolyte-Coated ImplantsJohn R Martin, MayLin T Howard, Sheryl Wang, et al.
European Journal of Biochemistry|February 15, 1993
Purification and characterization of recombinant human beta 1-4 galactosyltransferase expressed in Saccharomyces cerevisiaeC H Krezdorn, G Watzele, R B Kleene, et al.
Zeitschrift Fur Experimentelle Chirurgie, Transplantation, Und Kunstliche Organe : Organ Der Sektion Experimentelle Chirurgie Der Gesellschaft Fur Chirurgie Der DDR|January 1, 1988
[Peri-implantation enzymes and mineralization in bone tissue after implantation of bioactive vitroceramic material--a method for biomaterial testing for hard tissue substitutes. 2. Results of studies of vitroceramics and their modification by the admixture of metal oxides]H Reichelt, S Köhler, G Berger, et al.
Journal of Biomedical Materials Research. Part A|July 20, 2007
Effect of rapidly resorbable bone substitute materials on the temporal expression of the osteoblastic phenotype in vitroC Knabe, A Houshmand, G Berger, et al.
Genomics|November 1, 2002
The murine alpha(1)-proteinase inhibitor gene family: polymorphism, chromosomal location, and structureKaren W Barbour, FuSheng Wei, Camilynn Brannan, et al.
Molecular Pharmacology|October 26, 1999
Mechanisms of acquired resistance to thymidylate synthase inhibitors: the role of enzyme stabilityM E Kitchens, A M Forsthoefel, K W Barbour, et al.
Cancer Research|July 30, 2010
Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathwayXinna Zhang, Guohui Wan, Sizolwenkosi Mlotshwa, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1988
Pharmacology of SCH 34826, an orally active enkephalinase inhibitor analgesicR E Chipkin, J G Berger, W Billard, et al.
Journal of the American Academy of Dermatology|July 30, 1999
Sarcoidosis in a patient with AIDS: a manifestation of immune restoration syndromeP Mirmirani, T A Maurer, B Herndier, et al.
Pageof 97